Intake of Individual Flavonoids and Risk of Carcinogenesis: Overview of Epidemiological Evidence

References

• Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, et al.: Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One 8, e54318, 2013.
   PubMed Web of Science ®Google Scholar
• Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby I, et al.: Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev 17, 553–562, 2008.
   PubMed Web of Science ®Google Scholar
• Russo GL: Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 74, 533–544, 2007.
   PubMed Web of Science ®Google Scholar
• Yao H, Xu W, Shi X, and Zhang Z: Dietary flavonoids as cancer prevention agents. J Envrion Sci Health C Environ Carcinog Ecotoxicol Rev 29, 1–31, 2011.
   Google Scholar
• Kozlowska A, and Szostak-Wegierek D: Flavonoids – food sources and health benefits. Rocz Panstw Zakl Hig 65, 79–85, 2014.
   PubMedGoogle Scholar
• Nambiar D, and Singh RP: Advances in prostate cancer chemoprevention: a translational perspective. Nutr Cancer 65 (Suppl 1), 12–25, 2013.
   PubMed Web of Science ®Google Scholar
• Yang F, Song L, Wang G, Wang J, Xu Z, et al.: Quercetin in prostate cancer: Chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (Review). Oncol Rep 33, 2659–2668, 2015.
   PubMed Web of Science ®Google Scholar
• Jian L: Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 53, 217–226, 2009.
   PubMed Web of Science ®Google Scholar
• Johnsonn JJ, Bailey HH, and Mukhtar H: Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 17, 3–13, 2010.
   PubMed Web of Science ®Google Scholar
• Bouker KB, and Hilakivi-Clarke L: Genistein: does it prevent or promote breast cancer? Environ Health Perspect 108, 701–708, 2000.
   PubMed Web of Science ®Google Scholar
• McCann SE, Freudenheim JL, Marshall JR, and Graham S: Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 133, 1937–1942, 2003.
   PubMed Web of Science ®Google Scholar
• Hua X, Yu L, You R, Yang Y, Liao J, et al.: Association among dietary flavonoids, flavonoid subclasses and ovarian cancer risk: a meta-analysis. PLoS One 11, e0151134, 2016.
   PubMed Web of Science ®Google Scholar
• Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, et al.: Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17, 169–180, 2006.
   PubMed Web of Science ®Google Scholar
• Messina M, and Bennink M: Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Baillieres Clin Endocrinol Metab 12, 707–728, 1998.
   PubMed Web of Science ®Google Scholar
• Amararathna M, Johnston MR, and Vasantha Rupasinghe HP: Plant polyphenols as chemopreventive agents for lung cancer. Int J Mol Sci 17, 1352, 2016.
   PubMed Web of Science ®Google Scholar
• Hertog MG: Epidemiological evidence on potential health properties of flavonoids. Proc Nutr Soc 55, 385–397, 1996.
   PubMed Web of Science ®Google Scholar
• Neuhouser ML: Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50, 1–7, 2004.
   PubMed Web of Science ®Google Scholar
• Xie Y, Huang S, and Su Y: Dietary flavonols intake and risk of esophageal and gastric cancer: a meta-analysis of epidemiological studies. Nutrients 8, 91, 2016.
   PubMed Web of Science ®Google Scholar
• Woo HD, and Kim J: Dietary flavonoid intake and risk of stomach and colorectal cancer. World J Gastroenterol 19, 1011–1019, 2013.
   PubMed Web of Science ®Google Scholar
• Vermeulen E, Zamora-Ros R, Duell EJ, Lujan-Barroso L, Boeing H, et al.: Dietary flavonoid intake and esophageal cancer risk in the European prospective investigation into cancer and nutrition cohort. Am J Epidemiol 178, 570–581, 2013.
   PubMed Web of Science ®Google Scholar
• Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, et al.: Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control 21, 1597–1604, 2010.
   PubMed Web of Science ®Google Scholar
• Kyle JA, Sharp L, Little J, Duthie GG, and McNeill G: Dietary flavonoid intake and colorectal cancer: a case-control study. Br J Nutr 103, 429–436, 2010.
   PubMed Web of Science ®Google Scholar
• Kocic B, Kitic D, and Brankovic S: Dietary flavonoid intake and colorectal cancer risk: evidence from human population studies. J BUON 18, 34–43, 2013.
   PubMed Web of Science ®Google Scholar
• Le Marchand L: Cancer preventive effects of flavonoids – a review. Biomed Pharmacother 56, 296–301, 2002.
   PubMed Web of Science ®Google Scholar
• Peeters PH, Keinan-Boker L, van der Schouw YT, and Grobbe DE: Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 77, 171–183, 2003.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Rossi M, McLaughlin JK, Negri E, Talamini R, et al.: Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 16, 98–101, 2007.
   PubMed Web of Science ®Google Scholar
• Ekström AM, Serafini M, Nyren O, Wolk A, Bosetti C, et al.: Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol 22, 438–443, 2011.
   PubMed Web of Science ®Google Scholar
• Lin Y, Yngve A, Lagergren J, and Lu Y: A dietary pattern rich in lignans, quercetin and resveratrol decreases the risk of oesophageal cancer. Br J Nutr 112, 2002–2009, 2014.
   PubMed Web of Science ®Google Scholar
• Garcia-Closas R, Gonzalez CA, Agudo A, and Riboli E: Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10, 71–75, 1999.
   PubMed Web of Science ®Google Scholar
• Xu M, Chen YM, Huang J, Fang YJ, Huang WQ, et al.: Flavonoid intake from vegetables and fruits is inversely associated with colorectal cancer risk: a case-control study in China. Br J Nutr 116, 1275–1287, 2016.
   PubMed Web of Science ®Google Scholar
• Garcia-Closas R, Agudo A, Gonzalez CA, and Riboli E: Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 32, 154–158, 1998.
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, and Kolonel LN: Intake of flavonoids and lung cancer. J Natl Cancer Inst 92, 154–160, 2000.
   PubMed Web of Science ®Google Scholar
• Lagiou P, Samoli E, Lagiou A, Katsouyanni K, Peterson J, et al.: Flavonoid intake in relation to lung cancer risk: case-control study among women in Greece. Nutr Cancer 49, 139–143, 2004.
   PubMed Web of Science ®Google Scholar
• Graf BA, Milbury PE, and Blumberg JB: Flavonols, flavones, flavanones, and human health: epidemiological evidence. J Med Food 8, 281–290, 2005.
   PubMed Web of Science ®Google Scholar
• McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, et al.: Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53, 33–41, 2005.
   PubMed Web of Science ®Google Scholar
• He X, and Sun LM: Dietary intake of flavonoid subclasses and risk of colorectal cancer: evidence from population studies. Oncotarget 7, 26617–26627, 2016.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zheng J, Li Y, Xu DP, Li S, et al.: Natural polyphenols for prevention and treatment of cancer. Nutrients 8, 515, 2016.
   PubMed Web of Science ®Google Scholar
• Lam TK, Rotunno M, Lubin JH, Wacholder S, Consonni D, et al.: Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinogenesis 31, 634–642, 2010.
   PubMed Web of Science ®Google Scholar
• Grosso G, Micek A, Marranzano M, Mistretta A, and Giovannucci EL: Dietary polyphenols and cancer incidence: a comprehensive meta-analysis. Eur J Public Health 25 (Suppl 3), ckv175.177, 2015.
   Google Scholar
• Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, et al.: Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14, 805–808, 2005.
   PubMed Web of Science ®Google Scholar
• Cassidy A, Huang T, Rice MS, Rimm EB, and Tworoger SS: Intake of dietary flavonoids and risk of epithelial ovarian cancer. Am J Clin Nutr 100, 1344–1351, 2014.
   PubMed Web of Science ®Google Scholar
• Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, et al.: Flavonoids and ovarian cancer risk: a case-control study in Italy. Int J Cancer 123, 895–898, 2008.
   PubMed Web of Science ®Google Scholar
• Garavello W, Rossi M, McLaughlin JK, Bosetti C, Negri E, et al.: Flavonoids and laryngeal cancer risk in Italy. Ann Oncol 18, 1104–1109, 2007.
   PubMed Web of Science ®Google Scholar
• Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, et al.: Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev 16, 1621–1625, 2007.
   PubMed Web of Science ®Google Scholar
• Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, et al.: Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer 120, 1560–1564, 2007.
   PubMed Web of Science ®Google Scholar
• Petrick JL, Steck SE, Bradshaw PT, Trivers KF, Abrahamson PE, et al.: Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA). Br J Cancer 112, 1291–1300, 2015.
   PubMed Web of Science ®Google Scholar
• Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, et al.: Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15, 67–72, 2004.
   PubMed Web of Science ®Google Scholar
• Arem H, Bobe G, Sampson J, Subar AF, Park Y, et al.: Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort. Br J Cancer 108, 1168–1172, 2013.
   PubMed Web of Science ®Google Scholar
• Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR Jr, et al.: Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer 123, 664–671, 2008.
   PubMed Web of Science ®Google Scholar
• Ivey KL, Hodgson JM, Croft KD, Lewis JR, and Prince RL: Flavonoid intake and all-cause mortality. Am J Clin Nutr 101, 1012–1020, 2015.
   PubMed Web of Science ®Google Scholar
• Bo Y, Sun J, Wang M, Ding J, Lu Q, et al.: Dietary flavonoid intake and the risk of digestive tract cancers: a systematic review and meta-analysis. Sci Rep 6, 24836, 2016.
   PubMed Web of Science ®Google Scholar
• Cui L, Liu X, Tian Y, Xie C, Li Q, et al.: Flavonoids, flavonoid subclasses, and esophageal cancer risk: a meta-analysis of epidemiologic studies. Nutrients 8, 350, 2016.
   PubMed Web of Science ®Google Scholar
• Kuo SM: Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit Rev Oncog 8, 47–69, 1997.
   PubMed Web of Science ®Google Scholar
• Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, et al.: Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155, 381–386, 1995.
   PubMed Web of Science ®Google Scholar
• Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, et al.: Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17, 1344–1353, 2008.
   PubMed Web of Science ®Google Scholar
• Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, et al.: Dietary flavonoid intake and lung cancer – a population-based case-control study. Cancer 112, 2241–2248, 2008.
   PubMed Web of Science ®Google Scholar
• Magne Nde CB, Zingue S, Winter E, Creczynski-Pasa TB, Michel T, et al.: Flavonoids, breast cancer chemopreventive and/or chemotherapeutic agents. Curr Med Chem 22, 3434–3446, 2015.
   Web of Science ®Google Scholar
• Hoensch HP, Kirch W: Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int J Gastrointest Cancer 35, 187–195, 2005.
   PubMedGoogle Scholar
• Low YL, Taylor JI, Grace PB, Mulligan AA, Welch AA, et al.: Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer 56, 31–39, 2006.
   PubMed Web of Science ®Google Scholar
• Ganry O: Phytoestrogens and prostate cancer risk. Prev Med 41, 1–6, 2005.
   PubMed Web of Science ®Google Scholar
• Hedelin M, Löf M, Olsson M, Adlercreutz H, Sandin S, et al.: Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138, 938–945, 2008.
   PubMed Web of Science ®Google Scholar
• Nagata C: Factors to consider in the association between soy isoflavone intake and breast cancer risk. J Epidemiol 20, 83–89, 2010.
   PubMed Web of Science ®Google Scholar
• Taylor CK, Levy RM, Elliott JC, and Burnett BP: The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev 67, 398–415, 2009.
   PubMed Web of Science ®Google Scholar
• Wada K, Nakamura K, Tamai Y, Tsuji M, Kawachi T, et al.: Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer 133, 952–960, 2013.
   PubMed Web of Science ®Google Scholar
• Neill AS, Ibiebele TI, Lahmann PH, Hughes MC, Nagle CM, et al.: Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case-control studies. Br J Nutr 111, 1430–1440, 2014.
   PubMed Web of Science ®Google Scholar
• Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, et al.: Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 16, 538–545, 2007.
   PubMed Web of Science ®Google Scholar
• Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, et al.: Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12, 665–668, 2003.
   PubMed Web of Science ®Google Scholar
• Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, et al.: Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34, 86–89, 2004.
   PubMed Web of Science ®Google Scholar
• Akaza H: Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the “second human genome. Cancer Sci 103, 969–975, 2012.
   PubMed Web of Science ®Google Scholar
• Vastag B: Soy and prostate cancer study results mixed. J Natl Cancer Inst 99, 1364–1365, 2007.
   PubMedGoogle Scholar
• Sugiyama Y, Masumori N, Fukuta F, Yoneta A, Hida T, et al.: Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev 14, 1–4, 2013.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, et al.: Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 26, 1677–1683, 2008.
   PubMed Web of Science ®Google Scholar
• Messina MJ: Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 61, 117–131, 2003.
   PubMed Web of Science ®Google Scholar
• Ollberding NJ, Lim U, Wilkens LR, Setiawan VW, Shvetsov YB, et al.: Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst 104, 67–76, 2012.
   PubMed Web of Science ®Google Scholar
• Wang Y, Stevens VL, Shah R, Peterson JJ, Dwyer JT, et al.: Dietary flavonoid and proanthocyanidin intakes and prostate cancer risk in a prospective cohort of US men. Am J Epidemiol 179, 974–986, 2014.
   PubMed Web of Science ®Google Scholar
• Steiner C, Arnould S, Scalbert A, and Manach C: Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr 99 (E Suppl 1), ES78–ES108, 2008.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Sonoda T, Mori M, Miyanaga N, Okumura K, et al.: Dietary isoflavones may protect against prostate cancer in Japanese men. J Nutr 137, 1974–1979, 2007.
   PubMed Web of Science ®Google Scholar
• Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, et al.: Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 165, 802–813, 2007.
   PubMed Web of Science ®Google Scholar
• Lee AH, Su D, Pasalich M, Tang L, Binns CW, et al.: Soy and isoflavone intake associated with reduced risk of ovarian cancer in southern Chinese women. Nutr Res 34, 302–307, 2014.
   PubMed Web of Science ®Google Scholar
• Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, et al.: Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study. Cancer Epidemiol Biormarkers Prev 17, 2128–2135, 2008.
   PubMed Web of Science ®Google Scholar
• Adebamowo CA, Cho E, Sampson L, Katan MB, Spiegelman D, et al.: Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int J Cancer 114, 628–633, 2005.
   PubMed Web of Science ®Google Scholar
• Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al.: Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165, 514–523, 2007.
   PubMed Web of Science ®Google Scholar
• Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN, et al.: Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer 123, 927–932, 2008.
   PubMed Web of Science ®Google Scholar
• Guo K, Liang Z, Liu L, Li F, and Wang H: Flavonoids intake and risk of prostate cancer: a meta-analysis of observational studies. Andrologia 48, 1175–1182, 2016.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Bravi D, Talamini R, Parpinel M, Gnagnarella P, et al.: Flavonoids and prostate cancer risk: a study in Italy. Nutr Cancer 56, 123–127, 2006.
   PubMed Web of Science ®Google Scholar
• Golpour S, Rafie N, Safavi SM, and Miraghajani M: Dietary isoflavones and gastric cancer: a brief review of current studies. J Res Med Sci 20, 893–900, 2015.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Agudo A, Lujan-Barroso L, Romieu I, Ferrari P, et al.: Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 96, 1398–1408, 2012.
   PubMed Web of Science ®Google Scholar
• Wada K, Tsuji M, Tamura T, Konishi K, Kawachi T, et al.: Soy isoflavone intake and stomach cancer risk in Japan: From the Takayama study. Int J Cancer 137, 885–892, 2015.
   PubMed Web of Science ®Google Scholar
• Simons CC, Hughes LA, Arts IC, Goldbohm RA, van den Brandt PA, et al.: Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. Int J Cancer 125, 2945–2952, 2009.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, et al.: Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 684–693, 2007.
   PubMed Web of Science ®Google Scholar
• Nimptsch K, Zhang X, Cassidy A, Song M, O´Reilly EJ, et al.: Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am J Clin Nutr 103, 184–191, 2016.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Not C, Guino E, Lujan-Barroso L, Garcia RM, et al.: Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer Causes Control 24, 549–557, 2013.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Fedirko V, Trichopoulou A, Gonzalez CA, Bamia C, et al.: Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study. Int J Cancer 133, 2429–2443, 2013.
   PubMed Web of Science ®Google Scholar
• Molina-Montes E, Sanchez MJ, Zamora-Ros R, Bueno-de-Mesquita HB, Wark PA, et al.: Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer 139, 1480–1492, 2016.
   PubMed Web of Science ®Google Scholar
• Tang NP, Zhou B, Wang B, Yu RB, and Ma J: Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 39, 352–359, 2009.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Park Y, Hollenbeck AR, and Kitahara CM: Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 23, 1102–1108, 2014.
   PubMed Web of Science ®Google Scholar
• Arts IC, and Hollman PC: Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81 (1 Suppl), 317S–325S, 2005.
   PubMed Web of Science ®Google Scholar
• Touvier M, Druesne-Pecollo N, Kesse-Guyot E, Andreeva VA, Fezeu L, et al.: Dual association between polyphenol intake and breast cancer risk according to alcohol consumption level: a prospective cohort study. Breast Cancer Res Treat 137, 225–236, 2013.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang SM, Wu K, Willett WC, Fuchs CS, et al.: Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 164, 644–651, 2006.
   PubMed Web of Science ®Google Scholar
• Djuric Z, Severson RK, and Kato I: Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr Cancer 64, 351–360, 2012.
   PubMed Web of Science ®Google Scholar
• Wright ME, Mayne ST, Stolzenberg-Solomon RZ, Li Z, Pietinen P, et al.: Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol 160, 68–76, 2004.
   PubMed Web of Science ®Google Scholar
• Knekt P, Järvinen R, Seppänen R, Hellövaara M, Teppo L, et al.: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146, 223–230, 1997.
   PubMed Web of Science ®Google Scholar
• Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, et al.: Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89, 905–912, 2009.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yang H, and Holman CD: Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status. Breast Cancer Res Treat 118, 553–563, 2009.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola J Jr, et al.: Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat 116, 401–411, 2009.
   PubMed Web of Science ®Google Scholar
• Rosenberg Zand RS, Jenkins DJ, and Diamandis EP: Flavonoids and steroid hormone-dependent cancers. J Chromatogr B Analyt Technol Biomed Life Sci 777, 219–232, 2002.
   PubMed Web of Science ®Google Scholar
• Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, et al.: Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer 33, 20–25, 1999.
   PubMed Web of Science ®Google Scholar
• Oba S, Nagata C, Shimizu N, Shimizu H, Kametani M, et al.: Soy product consumption and the risk of colon cancer: a prospective study in Takayama, Japan. Nutr Cancer 57, 151–157, 2007.
   PubMed Web of Science ®Google Scholar
• Sak K: Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev 8, 122–146, 2014.
   PubMedGoogle Scholar
• Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, et al.: Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560–568, 2002.
   PubMed Web of Science ®Google Scholar
• Scalbert A, and Zamora-Ros R: Bridging evidence from observational and intervention studies to identify flavonoids most protective for human health. Am J Clin Nutr 101, 897–898, 2015.
   PubMed Web of Science ®Google Scholar
• Trock BJ, Hilakivi-Clarke L, and Clarke R: Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459–471, 2006.
   PubMed Web of Science ®Google Scholar
• Sak K: Site-specific anticancer effects of dietary flavonoid quercetin. Nutr Cancer 66, 177–193, 2014.
   PubMed Web of Science ®Google Scholar
• Garcia R, Gonzalez CA, Agudo A, and Riboli E: High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer 35, 212–214, 1999.
   PubMed Web of Science ®Google Scholar
• Wilson RT, Wang J, Chinchilli V, Richie JP, Virtamo J, et al.: Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol 170, 717–729, 2009.
   PubMed Web of Science ®Google Scholar
• Gates MA, Vitonis AF, Tworoger SS, Rosner B, Titus-Ernstoff L, et al.: Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer 124, 1918–1925, 2009.
   PubMed Web of Science ®Google Scholar
• Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, et al.: A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121, 2225–2232, 2007.
   PubMed Web of Science ®Google Scholar
• Goldbohm RA, Hertog MG, Brants HA, van Poppel G, and van den Brandt PA: Intake of flavonoids and cancer risk: a prospective cohort study. In Polyphenols in Food, ed. Armado R, Andersson H, Bardocz S, and Serra F (eds.). Luxembourg, Office for Official Publications of the European Communities, 1998, pp 159–166.
   Google Scholar
• Geybels MS, Verhage BA, Arts IC, van Schooten FJ, Goldbohm RA, et al.: Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer. Am J Epidemiol 177, 1388–1398, 2013.
   PubMed Web of Science ®Google Scholar
• Bertoia M, Albanes D, Mayne ST, Männistö S, Virtamo J, et al.: No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma. Int J Cancer 126, 1504–1512, 2010.
   PubMed Web of Science ®Google Scholar
• Nöthlings U, Murphy SP, Wilkens LR, Henderson BE, and Kolonel LN: Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol 166, 924–931, 2007.
   PubMed Web of Science ®Google Scholar
• Hirvonen T, Virtamo J, Korhonen P, Albanes D, and Pietinen P: Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12, 789–796, 2001.
   PubMed Web of Science ®Google Scholar
• Stefani ED, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, et al.: Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34, 100–110, 1999.
   PubMed Web of Science ®Google Scholar
• Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, et al.: Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 20, 1117–1127, 2009.
   PubMed Web of Science ®Google Scholar
• Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, et al.: Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154, 434–441, 2001.
   PubMed Web of Science ®Google Scholar
• Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, et al.: Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 91, 440–448, 2010.
   PubMed Web of Science ®Google Scholar
• Linseisen J, Piller R, Hermann S, and Chang-Claude J, German Case-Control Study: Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 110, 284–290, 2004.
   PubMed Web of Science ®Google Scholar
• Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, et al.: Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13, 407–415, 2002.
   PubMed Web of Science ®Google Scholar
• Horn-Ross PL, Hoggatt KJ, and Lee MM: Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 11, 43–49, 2002.
   PubMed Web of Science ®Google Scholar
• Horn-Ross PL, John EM, Canchola AJ, Stewart SL, and Lee MM: Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95, 1158–1164, 2003.
   PubMed Web of Science ®Google Scholar
• Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, et al.: Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health 11, 40, 2011.
   PubMed Web of Science ®Google Scholar
• dos Santos Silva I, Mangtani P, McCormack V, Bhakta D, McMichael AJ, et al.: Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study. Cancer Causes Control 15, 805–818, 2004.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang M, and Holman CD: Population versus hospital controls in the assessment of dietary intake of isoflavone for case-control studies on cancers in China. Nutr Cancer 65, 390–397, 2013.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S, et al.: Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95, 906–913, 2003.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xie X, Lee AH, and Binns CW: Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer 49, 125–130, 2004.
   PubMed Web of Science ®Google Scholar
• Tang L, Lee AH, Xu F, Zhang T, Lei J, et al.: Soya and isoflavone intakes associated with reduced risk of oesophageal cancer in north-west China. Public Health Nutr 18, 130–134, 2015.
   PubMed Web of Science ®Google Scholar
• Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, et al.: Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr 95, 147–154, 2012.
   PubMed Web of Science ®Google Scholar
• Shin A, Lee J, Lee J, Park MS, Park JW, et al.: Isoflavone and soyfood intake and colorectal cancer risk: a case-control study in Korea. PLoS One 10, e0143228, 2015.
   PubMed Web of Science ®Google Scholar
• Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, et al.: Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int J Cancer 124, 1644–1649, 2009.
   PubMed Web of Science ®Google Scholar
• Liu YT, Fan YY, Xu CH, Lin XL, Lu YK, et al.: Habitual consumption of soy products and risk of nasopharyngeal carcinoma in Chinese adults: a case-control study. PLoS One 8, e77822, 2013.
   PubMed Web of Science ®Google Scholar
• Peterson JJ, Dwyer JT, Jacques PF, and McCullough ML: Improving the estimation of flavonoid intake for study of health outcomes. Nutr Rev 73, 553–576, 2015.
   PubMed Web of Science ®Google Scholar
• Linseisen J, and Rohrmann S: Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet-cancer relationship in humans. Eur J Nutr 47 (Suppl 2), 60–68, 2008.
   PubMed Web of Science ®Google Scholar
• Rossi M, and La Vecchia C: Flavonoids and the risk of ovarian cancer. Am J Clin Nutr 100, 1217–1219, 2014.
   PubMed Web of Science ®Google Scholar
• Rossi M, Edefonti V, Parpinel M, Lagiou P, Franchi M, et al.: Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case-control study in Italy. Br J Cancer 109, 1914–1920, 2013.
   PubMed Web of Science ®Google Scholar
• Yan L, and Spitznagel EL: Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89, 1155–1163, 2009.
   PubMed Web of Science ®Google Scholar
• Christensen KY, Naidu A, Parent ME, Pintos J, Abrahamowicz M, et al.: The risk of lung cancer related to dietary intake of flavonoids. Nutr Cancer 64, 964–974, 2012.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ho SC, Lin F, Cheng S, Fu J, et al.: Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. Cancer Sci 101, 501–507, 2010.
   PubMed Web of Science ®Google Scholar
• Arts IC: A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J Nutr 138, 1561S–1566S, 2008.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Ferrari P, Gonzalez CA, Tjonneland A, Olsen A, et al.: Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Breast Cancer Res Treat 139, 163–176, 2013.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Sacerdote C, Ricceri F, Weiderpass E, Roswall N, et al.: Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Cancer 111, 1870–1880, 2014.
   PubMed Web of Science ®Google Scholar
• Petrick JL, Steck SE, Bradshaw PT, Chow WH, Engel LS, et al.: Dietary flavonoid intake and Barrett's esophagus in western Washington State. Ann Epidemiol 25, 730–735, 2015.
   PubMed Web of Science ®Google Scholar
• Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, et al.: Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. Am J Clin Nutr 91, 722–728, 2010.
   PubMed Web of Science ®Google Scholar
• Woo HD, Lee J, Choi IJ, Kim CG, Lee JY, et al.: Dietary flavonoids and gastric cancer risk in a Korean population. Nutrients 6, 4961–4973, 2014.
   PubMed Web of Science ®Google Scholar
• Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE: Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 98, 388–396, 2007.
   PubMed Web of Science ®Google Scholar
• Romagnolo DF, and Selmin OI: Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31, 206–238, 2012.
   PubMedGoogle Scholar
• Lei L, Yang Y, He H, Chen E, Du L, et al.: Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies. Oncotarget 7, 73573–73592, 2016.
   PubMed Web of Science ®Google Scholar
• Rossi M, Bosetti C, Negri E, Lagiou P, and La Vecchia C: Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer 62, 871–877, 2010.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Knaze V, Rothwell JA, Hemon B, Moskal A, et al.: Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr 55, 1359–1375, 2016.
   PubMed Web of Science ®Google Scholar
• van Die MD, Bone KM, Williams SG, and Pirotta MV: Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int 113, E119–E130, 2014.
   PubMed Web of Science ®Google Scholar
• Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, et al.: Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control 19, 813–818, 2008.
   PubMed Web of Science ®Google Scholar
• Messina MJ, and Wood CE: Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 7, 17, 2008.
   PubMed Web of Science ®Google Scholar
• Cotterchio M, Boucher BA, Kreiger N, Mills CA, and Thompson LU: Dietary phytoestrogen intake—lignans and isoflavones—and breast cancer risk (Canada). Cancer Causes Control 19, 259–272, 2008.
   PubMed Web of Science ®Google Scholar
• Lee SA, Shu XO, Li H, Yang G, Cai H, et al.: Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr 89, 1920–1926, 2009.
   PubMed Web of Science ®Google Scholar
• Xie Q, Chen ML, Qin Y, Zhang QY, Xu HX, et al.: Isoflavone consumption and risk of breast cancer: a dose–response meta-analysis of observational studies. Asia Pac J Clin Nutr 22, 118–127, 2013.
   PubMed Web of Science ®Google Scholar
• Messina M, McCaskill-Stevens W, and Lampe JW: Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98, 1275–1284, 2006.
   PubMed Web of Science ®Google Scholar
• Wan YL, and Crosbie EJ: Soy intake and endometrial cancer risk varies according to study population. BJOG 122, 311, 2015.
   PubMed Web of Science ®Google Scholar
• Woo HD, and Kim J: Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS One 8, e75604, 2013.
   PubMed Web of Science ®Google Scholar
• Dong JY, and Qin LQ: Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125, 315–323, 2011.
   PubMed Web of Science ®Google Scholar
• Chen M, Rao Y, Zheng Y, Wei S, Li Y, et al.: Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies. PLoS One 9, e89288, 2014.
   PubMed Web of Science ®Google Scholar
• Michikawa T, Inoue M, Sawada N, Tanaka Y, Yamaji T, et al.: Plasma isoflavones and risk of primary liver cancer in Japanese women and men with hepatitis virus infection: a nested case-control study. Cancer Epidemiol Biomarkers Prev 24, 532–537, 2015.
   PubMed Web of Science ®Google Scholar
• Hedelin M, Löf M, Andersson TM, Adlercreutz H, and Weiderpass E: Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 20, 308–317, 2011.
   PubMed Web of Science ®Google Scholar
• Hedelin M, Bälter KA, Chang ET, Bellocco R, Klint A, et al.: Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 66, 1512–1520, 2006.
   PubMed Web of Science ®Google Scholar
• Cho YA, Kim J, Park KS, Lim SY, Shin A, et al.: Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status. Eur J Clin Nutr 64, 924–932, 2010.
   PubMed Web of Science ®Google Scholar
• Travis RC, Allen NE, Appleby PN, Spencer EA, Roddam AW, et al.: A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int J Cancer 122, 705–710, 2008.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola J Jr, et al.: Isoflavone, polymorphisms in estrogen recepto genes and breast cancer risk in case-control studies in Japanese, Japanese Barazilians and non-Japanese Brazilians. Cancer Sci 100, 927–933, 2009.
   PubMed Web of Science ®Google Scholar